Senior Vice President, Research, External Science & Innovation, and Non-Clinical and Translational Sciences, Allergan
Don joined Allergan in 2014 and leads many of the preclinical efforts and clinical pharmacology for the organization and the External Science & Innovation (ESI) group within R&D, the group that partners with Business Development to evaluate and implement partnerships, licensing, and acquisitions. He has been involved in most Allergan deals completed since 2015 and sits on numerous JSCs. He also chairs the Allergan governance committee for all pre-POC development programs. With over twenty years of pharmaceutical and academia R&D and management experience, Don has been involved in a variety of pre-clinical drug discovery and Ph1/Ph2 clinical research areas and environments, including the entry of more than 25 compounds into development. Previous roles included heading the Emerging Innovations Unit at AstraZeneca, leading multiple groups at the Pfizer Saint Louis site, and heading the CNS Discovery organization at Pharmacia.